improved peptide pharmaceuticals for insulin resistance Abstract of the disclosure described herein are methods of synthesis and therapeutic uses of covalently modified peptides and / or proteins. the covalently modified peptides and / or proteins allow for improved pharmaceutical properties of peptide and protein-based therapeutics. abstract of patent summary: "improved peptide pharmaceuticals for insulin resistance". Synthesis methods and therapeutic uses of covalently modified peptides and / or proteins are described herein. covalently modified peptides and / or proteins provide improved pharmaceutical properties of peptide and protein based therapeutics. wsgr docket no .: 38617.703.601improved peptide pharmaceuticals for insulin resistance abstract of the disclosure described herein are methods of syntheses and therapeutic uses of covalently modified peptides and/or proteins. the covalently modified peptides and/or proteins allow for improved pharmaceutical properties of peptide and protein-based therapeutics. tradução do resumo resumo patente de invenção: "produtos farmacêuticos de peptídeo melhorados para resistência à insulina". são descritos aqui métodos de sínteses e usos terapêuticos de peptídeos e/ou proteínas covalentemente modificados. os peptídeos e/ou proteínas covalentemente modificados provêm propriedades farmacêuticas melhoradas de produtos terapêuticos com base em peptídeo e proteína. wsgr docket no.: 38617.703.601
